Conference
Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial
Abstract
Purpose/Objective(s) Whole brain radiotherapy (WBRT) has historically been the main instrument to decrease intracranial progression after resection of brain metastases. The previously reported NCCTG N107C/CEC.3 (Alliance) randomized phase III clinical trial of WBRT vs. stereotactic radiosurgery (SRS) demonstrated that overall survival did not significantly differ between arms, while SRS was associated with less cognitive decline than WBRT. …
Authors
Breen W; Dooley KE; Twohy E; Brown PD; Ballman K; Cerhan JH; Urbanic JJ; Whitton AC; Greenspoon J; Parney IF
Volume
114
Pagination
pp. 1063-1064
Publisher
Elsevier
Publication Date
December 2022
DOI
10.1016/j.ijrobp.2022.09.012
Conference proceedings
International Journal of Radiation Oncology • Biology • Physics
Issue
5
ISSN
0360-3016